Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2

Nature Communications

Volumn 4, Issue , 2013, Pages

  Guilhamon, Paul ^a   Eskandarpour, Malihe ^a   Halai, Dina ^b   Wilson, Gareth A ^a   Feber, Andrew ^a   Teschendorff, Andrew E ^a   Gomez, Valenti ^a   Hergovich, Alexander ^a   Tirabosco, Roberto ^b   Fernanda Amary, M ^b   Baumhoer, Daniel ^c   Jundt, Gernot ^c   Ross, Mark T ^d   Flanagan, Adrienne M ^a,b   Beck, Stephan ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d ILLUMINA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYGLUTARIC ACID; ISOCITRATE DEHYDROGENASE; OXYGENASE; RETINOIC ACID RECEPTOR; TET2 OXYGENASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EBF1; UNCLASSIFIED DRUG; ALPHA-HYDROXYGLUTARATE; DNA BINDING PROTEIN; EBF1 PROTEIN, HUMAN; GLUTARIC ACID DERIVATIVE; IDH1 PROTEIN, HUMAN; ISOCITRATE DEHYDROGENASE 2, HUMAN; ONCOPROTEIN; TET2 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

BLOOD SYSTEM DISORDER; CANCER; CYTOLOGY; DISEASE SEVERITY; ETIOLOGY; FUNCTIONAL ROLE; GENE EXPRESSION; GENOMICS; META-ANALYSIS; METABOLITE; MUTATION; PHENOTYPE; PROTEIN; TUMOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BILE DUCT CARCINOMA; CHONDROSARCOMA; CHROMATIN IMMUNOPRECIPITATION; DEMETHYLATION; DNA METHYLATION; GENE; GLIOMA; HUMAN; META ANALYSIS; METHYLATION; MUTANT; NEOPLASM; PHENOTYPE; WESTERN BLOTTING; BILE DUCT TUMOR; BONE TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; PATHOLOGY; SIGNAL TRANSDUCTION;

BILE DUCT NEOPLASMS; BONE NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHOLANGIOCARCINOMA; CHONDROSARCOMA; DNA METHYLATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; GLUTARATES; HUMANS; ISOCITRATE DEHYDROGENASE; LEUKEMIA, MYELOID, ACUTE; MUTATION; NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 84885848576     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3166     Document Type: Article

References (38)

1. Tang, C.-H. Molecular mechanisms of chondrosarcoma metastasis. Biomedicine. 2, 92-98 (2012).
2. Amary, M. F. et al. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J. Pathol. 224, 334-343 (2011).
3. Amary, M. F. et al. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat. Genet. 43, 1262-1265 (2011).
4. Dang, L., Jin, S. & Su, S. M. IDH mutations in glioma and acute myeloid leukemia. Trends Mol. Med. 16, 387-397 (2010).
5. Wang, P. et al. Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene 32, 3091-3100 (2012).
6. Xu, W. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19, 17-30 (2011).
7. Turcan, S. et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479-483 (2012).
8. Figueroa, M. E. et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18, 553-567 (2010).
9. Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935 (2009).
10. He, Y. F. et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303-1307 (2011).
11. Ito, S. et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300-1303 (2011).
12. Bibikova, M. et al. High density DNA methylation array with single CpG site resolution. Genomics 98, 288-295 (2011).
13. Rakyan, V. K., Down, T. A., Balding, D. J. & Beck, S. Epigenome-wide association studies for common human diseases. Nat. Rev. Genet. 12, 529-541 (2011).
14. Portela, A. & Esteller, M. Epigenetic modifications and human disease. Nat. Biotechnol. 28, 1057-1068 (2010).
15. Ye, D., Xiong, Y. & Guan, K. L. The mechanisms of IDH mutations in tumorigenesis. Cell. Res. 22, 1102-1104 (2012).
16. Khulan, B. et al. Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res. 16, 1046-1055 (2006).
17. Bailey, T. L. et al. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 37, W202-W208 (2009).
18. Eckhardt, F. et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet. 38, 1378-1385 (2006).
19. Li, Y. et al. The DNA methylome of human peripheral blood mononuclear cells. PLoS Biol. 8, e1000533 (2010).
20. Ryan, R. J. & Bernstein, B. E. Molecular biology. Genetic events that shape the cancer epigenome. Science 336, 1513-1514 (2012).
21. Tarpey, P. S. et al. Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nat. Genet . (e-pub ahead of print 16 June 2013; doi:10.1038/ng.2668).
22. Weissmann, S. et al. Landscape of TET2 mutations in acute myeloid leukemia. Leukemia 26, 934-942 (2012).
23. Kim, Y. H. et al. TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations. J. Clin. Pathol. 64, 850-852 (2011).
24. Tang, X. H. & Gudas, L. J. Retinoids, retinoic acid receptors, and cancer. Annu. Rev. Pathol. 6, 345-364 (2011).
25. Soprano, K. J. & Soprano, D. R. Retinoic acid receptors and cancer. J. Nutr. 132, 3809S-3813S (2002).
26. Duncan, C. G. et al. A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation. Genome Res. 22, 2339-2355 (2012).
27. Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290 (2010).
28. Maier, H. et al. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat. Immunol. 5, 1069-1077 (2004).
29. Treiber, T. et al. Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin. Immunity 32, 714-725 (2010).
30. Thirlwell, C. et al. Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip. Methods 52, 248-254 (2010).
31. Bolstad, B. M. preprocessCore: a collection of pre-processing functions. R package version 1.18.0.
32. Yang, Y. H. marray: exploratory analysis for two-color spotted microarray data. R package version 1.34.0 (2009).
33. Day, A. heatmap.plus: heatmap with more sensible behavior. R package version 1.3 (2007).
34. Warnes, G. R. gtools: various R programming tools. R package version 2.7.0. (http://CRAN.R-project.org/package=gtools) (2012).
35. Teschendorff, A. E. et al. An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One 4, e8274 (2009).
36. Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. J. Roy. Stat. Soc. B Met. 57, 289-300 (1995).
37. Krueger, F., Kreck, B., Franke, A. & Andrews, S. R. DNA methylome analysis using short bisulfite sequencing data. Nat. Methods. 9, 145-151 (2012).
38. Krueger, F. & Andrews, S. R. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 27, 1571-1572 (2011).